Pharmacotherapy of obstructive sleep apnea

Author： Lin Chia Mo Huang Yu Shu Guilleminault Christian

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 841-857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Treatment of Obstructive Sleep Apnea

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1418-1425

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Morbidity and Mortality in Obstructive Sleep Apnea

Current Pharmaceutical Design, Vol. 14, Iss. 32, 2008-11 ,pp. : 3466-3473

Bentham Science Publishers

Access to resources Recommend Favorite

Obstructive Sleep Apnea: What Does the Cardiovascular Physician Need to Know?

By Nancy A. Collop

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 2, 2005-01 ,pp. : 71-81

Adis International

Access to resources Recommend Favorite

Upregulating substance P levels to treat obstructive sleep apnea

By Ursavas Ahmet

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 583-588

Informa Healthcare

Access to resources Recommend Favorite

Obstructive Sleep Apnea and Autoimmune Rheumatic Disease: Is there Any Link?

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 5, 2013-01 ,pp. : 362-367

Bentham Science Publishers

Access to resources Recommend Favorite